Formidable Asset Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$457K Buy
2,278
+589
+35% +$127K 0.07% 244
2026
Q1
$349K Buy
1,689
+477
+39% +$98.7K 0.05% 290
2025
Q4
$217K Buy
+1,212
New +$242K 0.03% 370
2024
Q2
Sell
-1,078
Closed -$166K 407
2024
Q1
$166K Buy
+1,078
New +$164K 0.03% 341
2023
Q1
Sell
-1,314
Closed -$203K 326
2022
Q4
$203K Buy
+1,314
New +$194K 0.05% 278
2022
Q1
Sell
-1,314
Closed -$209K 351
2021
Q4
$209K Hold
1,314
0.04% 288
2021
Q3
$218K Sell
1,314
-85
-6% -$14.5K 0.04% 313
2021
Q2
$232K Buy
+1,399
New +$231K 0.05% 271
2021
Q1
Sell
-1,399
Closed -$235K 309
2020
Q4
$235K Hold
1,399
0.05% 235
2020
Q3
$216K Hold
1,399
0.06% 216
2020
Q2
$246K Buy
+1,399
New +$220K 0.07% 202

Other funds holding FBT

Formidable Asset Management's FBT Position: Q2 2026 in Review

Formidable Asset Management increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 35% in Q2 2026, buying an estimated $127K and bringing the position to 2,278 shares worth $457K. The position accounts for 0.07% of the portfolio, ranked #244.

Formidable Asset Management first reported a position in FBT in Q2 2020 and has held it in 11 quarters since. 66 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • Formidable Asset Management held 2,278 shares of First Trust NYSE Arca Biotechnology Index Fund worth $457K as of Q2 2026.
  • Formidable Asset Management bought 589 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $127K.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.07% of Formidable Asset Management's portfolio in Q2 2026, its #244 holding.
  • Formidable Asset Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2020 and has held it in 11 quarters since.
  • 66 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Formidable Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.